Comparing cardiovascular risk prediction scores.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative.Menopause (New York, N.Y.) · 2021
   Trial
2. Validating the Framingham Hypertension Risk Score: A 4-year follow-up from the Brazilian Longitudinal Study of the Adult Health (ELSA-Brasil).Journal of clinical hypertension (Greenwich, Conn.) · 2020
   Trial
3. Statin therapy in primary and secondary cardiovascular disease prevention.Current atherosclerosis reports · 2024
   Review
4. Recommendations for statin management in primary prevention: disparities among international risk scores.European heart journal · 2024
   Article
5. Discrimination between Obstructive Coronary Artery Disease and Cardiac Syndrome X in Women with Typical Angina and Positive Exercise Test; Utility of Cardiovascular Risk Calculators.Medicina (Kaunas, Lithuania) · 2019
   Article
6. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.BMJ (Clinical research ed.) · 2018
   Article
7. The Veterans Affairs Cardiac Risk Score: Recalibrating the Atherosclerotic Cardiovascular Disease Score for Applied Use.Medical care · 2017
   Article
8. Use and Customization of Risk Scores for Predicting Cardiovascular Events Using Electronic Health Record Data.Journal of the American Heart Association · 2017
   Article
9. Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study.Drug safety · 2016
   Article
10. Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies.Drugs · 2015
    Review

Corrections and comments

• Comment on
  An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.2015

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as